New ultra-sensitive immunoassay platform for blood-based neurodegenerative biomarker detection – Keystone Symposium 2023

Neurodegenerative disease markers like neurofilament light protein (NFL) and phosphorylated Tau 181 (p-Tau) can be detected in cerebrospinal fluid (CSF) and are already being used in diagnosis and to guide therapeutic development. However, broad adoption of these tests is hindered by the invasive nature and high cost of CSF sampling. Plasma-based biomarkers are much easier […]